VEGFR2/CD309 antibody (APC)
Quick Overview for VEGFR2/CD309 antibody (APC) (ABIN7648943)
Target
See all VEGFR2/CD309 (VEGFR2) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- APC-Linked Anti-Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Polyclonal Antibody
-
Purification
- Protein A + Protein G affinity chromatography
-
Immunogen
- RPB367Hu01Recombinant Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
-
Isotype
- IgG1 kappa
-
-
-
-
Application Notes
- For flow cytometry, the suggested use of this reagent is 1-5 μL per 10^6 cells in 100 μL volume. Optimal working dilutions could be determined by end user.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store at 4°C, protected from prolonged exposure to light.
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Alternative Name
- Vascular Endothelial Growth Factor Receptor 2
-
Background
- CD309, FLK1, VEGFR, KDR, A Type III Receptor Tyrosine Kinase, Kinase Insert Domain Receptor, Kinase Insert Domain Receptor, Fetal Liver Kinase-1
-
UniProt
- P35968
-
Pathways
- RTK Signaling, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Target
-